WallStSmart
MRKR

Marker Therapeutics Inc

NASDAQ: MRKR · HEALTHCARE · BIOTECHNOLOGY

$1.46
+0.69% today

Updated 2026-04-30

Market cap
$24.18M
P/E ratio
P/S ratio
6.82x
EPS (TTM)
$-0.79
Dividend yield
52W range
$1 – $2
Volume
0.1M

Marker Therapeutics Inc (MRKR) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20062007200820092010201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-1.19M$-1.23M$-714425.00$-1.12M$-925041.00$-1.31M$-1.57M$-694583.00$-2.19M$-4.34M$-6.51M$-8.44M$-14.48M$-18.28M$-20.03M$-27.28M$-26.97M$-16.44M$-10.91M$-12.01T
Capital expenditures$0.00$22426.00$22426.00$0.00$0.00$0.00$0.00$0.00$0.00$147668.00$147668.00$147668.00$147668.00$374987.00$9.25M$3.13M$3.00$1.00$0.00$0.00
Depreciation
Stock-based comp$964222.00$234168.00$2.53M$2.29M$1.26M$2.44M$132093.00$1.39M$1.71M$1.56M$2.74M$16.35M$5.36M$5.23M$5.96M$3.30M$858269.00$245864.00$537.54B
Free cash flow$-1.19M$-1.25M$-736851.00$-1.12M$-925041.00$-1.31M$-1.57M$-694583.00$-2.19M$-4.49M$-6.66M$-8.59M$-14.63M$-18.66M$-29.29M$-30.41M$-26.97M$-16.44M$-10.91M$-12.01T
Investing cash flow
Financing cash flow
Dividends paid
Share repurchases
Debt repayment
Net change in cash$14750.00$93355.00$6.43M$-2.72M$56.62M$-17.84M$-22.55M